Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT vs CCRT after Induction Chemo in NPC
NCT03015727Phase 3Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Dec 2016
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03015727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03015727.